Skip to main content
. 2021 Mar 29;33(2):293–300. doi: 10.1093/icvts/ivab067

Table 3:

Patient follow-up

Group 1 (1999–2006) Group 2 (2007–2013) Group 3 (2014–2020)
Total number of patients 23 7 16
Number of TEVAR, n (%) 17 (74) 7 (100) 16 (100)
Deaths, n (%) 7 (30) 2 (28) 2 (12.5)
Loss of FU before 1 year, n (%) 7 (30) 3 (43) 8 (50)
FU >1 year, n (%) 9 (39) 2 (29) 7 (44)
FU >3 years, n (%) 8 (35) 1 (14) 3 (19)
FU >5 years, n (%) 6 (26) 1 (14) 1 (6)
FU >10 years, n (%) 6 (26) 1 (14) 0 (0)

TEVAR: thoracic endovascular repair; FU: follow-up